Log In

Forgot Password?
Create New Account

Loading... please wait

2021 Annual Meeting | Neuro-rehabilitation Posters

This program spans the entire conference
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Neuro-rehabilitation
0.00 credit

Program Materials Program Evaluations

Event Timeline
07:00 AM - 05:00 PM EDT Abstract 001 - Brain Resting Connectivity Changes in Post-Stroke Spasticity Treated with Botulinum Toxin-A
Petr Hlustik, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 002 - Patient Perceptions of Spasticity and Treatment Satisfaction Over the Course of a Botulinum Neurotoxin A (BoNT-A) Treatment Cycle: An Ethnographic Study of Stroke Survivors
07:00 AM - 05:00 PM EDT Abstract 003 - Impact of Patient Input on the Study Execution of an Observational Study Assessing the Effectiveness of AbobotulinumtoxinA Treatment in Leg Spasticity Management in Adults
07:00 AM - 05:00 PM EDT Abstract 004 - Real-life data on the time to retreatment with botulinum toxin A in upper limb spasticity management
07:00 AM - 05:00 PM EDT Abstract 005 - Using resting-state electroencephalography to predict motor function improvement in spinal cord injury patients: a machine learning approach.
Kevin Pacheco-Barrios, MD
07:00 AM - 05:00 PM EDT Abstract 006 - Symptom amelioration in 798 patients with complex neurological disorders following a 5-day intensive multimodal neurorehabilitation program: Chart review
Matthew M. Antonucci, DC, DACNB, FACFN
07:00 AM - 05:00 PM EDT Abstract 007 - Pain Prevalence, Severity and Interference in Ambulatory People with Multiple Sclerosis and Self-Reported Spasticity
Lucinda L. Hugos, PT
07:00 AM - 05:00 PM EDT Abstract 008 - The Influence of Concomitant Traumatic Brain Injury (TBI) on the Survival, and Neurological and Functional Recovery after Traumatic Spinal Cord Injury (SCI): Analysis of a Cohort of 499 cases from the Third National Spinal Cord Injury Study.
Julio C. Furlan, MD, PhD, MBA, MSc, FAAN
07:00 AM - 05:00 PM EDT Abstract 009 - Disability And Dependency After Guillain-Barré Syndrome In Colombia: Follow Up Of Neuroviruses Emerging In The Americas Study
David Acero-Garces, MD
07:00 AM - 05:00 PM EDT Abstract 010 - Rehabilitation in patients with multiple sclerosis and telerehabilitation technologies during the COVID-19 pandemic in Western Siberia.
Stella Sivertceva
07:00 AM - 05:00 PM EDT Abstract 011 - Investigating the Role of the Claustrum in Consciousness Recovery Following Severe Brain Injury
Adeeb M. Narangoli, MD
07:00 AM - 05:00 PM EDT Abstract 012 - Telerehabilitation of Cognitive Functioning with Combined Transcranial Direct Current Stimulation and Computerized Adaptive Cognitive Training in Traumatic Brain Injury: A Case Report
Tehila Eilam-Stock, PhD
07:00 AM - 05:00 PM EDT Abstract 013 - Impact of Cognitive Rehabilitation on Quality of Life in Patients with Multiple Sclerosis
Megan Hyland, MD
Faculty Disclosures
No disclosure on file
Jorge Jacinto Jorge Jacinto has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz, Ipsen, Allergan. Jorge Jacinto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merz, Allergan, Ipsen.
Lucinda L. Hugos, PT Ms. Hugos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW Pharmaceuticals. Ms. Hugos has received personal compensation in the range of $0-$499 for serving as a Consultant for Evidera, Inc.. Ms. Hugos has received personal compensation in the range of $0-$499 for serving as a Consultant for Techspert.io Ltd.. Ms. Hugos has received research support from Portland VA. Ms. Hugos has received research support from Oregon Health & Science University. Ms. Hugos has received research support from Oregon Health & Science University. Ms. Hugos has received publishing royalties from a publication relating to health care.
Beatriz Parra No disclosure on file
Petr Kanovsky, PhD Dr. Kanovsky has nothing to disclose.
Kevin Pacheco-Barrios, MD Dr. Pacheco-Barrios has nothing to disclose.
Stella Sivertceva Stella Sivertceva has nothing to disclose.
Allan George Mr. George has nothing to disclose.
Felipe Fregni No disclosure on file
Matthew M. Antonucci, DC, DACNB, FACFN Dr. Antonucci has received stock or an ownership interest from TBIC, Inc. An immediate family member of Dr. Antonucci has received stock or an ownership interest from Carrick Institute.
Pascal Maisonobe No disclosure on file
Alberto Esquenazi, MD Dr. Esquenazi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen and Allergan. Dr. Esquenazi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen and Allergan. The institution of Dr. Esquenazi has received research support from Ipsen, Allergan and Merz.
Julio C. Furlan, MD, PhD, MBA, MSc, FAAN The institution of Dr. Furlan has received research support from Wings for Life Spinal Cord Research Foundation. The institution of Dr. Furlan has received research support from Craig H Neilsen Foundation. The institution of Dr. Furlan has received research support from Ontario Neurotrauma Foundation. The institution of Dr. Furlan has received research support from Cervical Spine Research Society. The institution of Dr. Furlan has received research support from J P Bickell Foundation. The institution of Dr. Furlan has received research support from Praxis Spinal Cord Institute. The institution of Dr. Furlan has received research support from Cervical Spine Research Society.
Allison Brashear, MD, MBA, FAAN Dr. Brashear has received personal compensation for serving as an employee of McKnight Brain Res Found. Dr. Brashear has received personal compensation for serving as an employee of American Board of Psychiatry and Neurology. Dr. Brashear has received personal compensation for serving as an employee of University of Buffalo. Dr. Brashear has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN. Dr. Brashear has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for McKnight Brain Research Foundation i. Dr. Brashear has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Care Directions. Dr. Brashear has stock in Caredirections . The institution of Dr. Brashear has received research support from NINDS. Dr. Brashear has received publishing royalties from a publication relating to health care. Dr. Brashear has received personal compensation in the range of $500-$4,999 for serving as a study section reviewer with NIH. Dr. Brashear has received personal compensation in the range of $0-$499 for serving as a Adminstrative board -travel reimbursement with AAMC.
Tehila Eilam-Stock, PhD Dr. Eilam-Stock has nothing to disclose.
Adeeb M. Narangoli, MD Mr. Narangoli has nothing to disclose.
Petr Hlustik, MD, PhD The institution of Prof. Hlustik has received research support from Czech Health Research Council (AZV CR).
Megan Hyland, MD The institution of Dr. Hyland has received research support from Biogen. The institution of Dr. Hyland has received research support from PCORI.
Stephen Ashford No disclosure on file
Julia Norton, BA Julia Norton has nothing to disclose.
Nicholas D. Schiff, MD Dr. Schiff has received publishing royalties from a publication relating to health care. Dr. Schiff has received personal compensation in the range of $500-$4,999 for serving as a study section member with NIH. Dr. Schiff has a non-compensated relationship as a Guidelines Panel Member with AAN that is relevant to AAN interests or activities.
Michelle Cameron, MD Dr. Cameron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwich Biosciences/Jazz . Dr. Cameron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Adamas Pharmaceuticals. Dr. Cameron has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Cameron has received research support from National MS Society. The institution of Dr. Cameron has received research support from Department of Veterans Affairs. Dr. Cameron has received publishing royalties from a publication relating to health care.
Daniela Zuluaga Lotero No disclosure on file
Marcel Simis, MD, PhD No disclosure on file
Leigh E. Charvet, PhD Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare. Dr. Charvet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for YBrain. Dr. Charvet has stock in Johnson&Johnson.
David Acero-Garces, MD The institution of Dr. Acero-Garces has received research support from Ministry of Science, Technology and Innovation of Colombia.
Pavel Hok, MD Dr. Hok has nothing to disclose.